to EMR Systems for Rapid Access to ECG, Stress, and Holter Tests

BOTHELL, Wash.–(EMWNews)–Cardiac Science today announced the launch of its HeartCentrix^®

6.2 data management product for the physician office. HeartCentrix is

the only solution that connects Burdick^®

and Quinton^®

equipment to an EMR system, giving access to test results remotely and

across locations with a single

sign-on from within the EMR itself. Cardiac Science (NASDAQ:CSCX) is

a global leader in advanced cardiac diagnosis, resuscitation,

rehabilitation, and informatics products.

“With HeartCentrix, our GEMMS ONE^®

electronic medical record (EMR) system now provides immediate access to

patient information and we don’t have to worry

about losing the hard copy of test results,”

said Dr. David Griffen from Heart Clinic Arkansas. “If

a patient suddenly presents with chest pain, we can go to his electronic

chart immediately for the critical information we need. It’s

all right there at our fingertips.”

HeartCentrix saves time and paper, eliminates errors, helps to ensure

patient safety, and communicates bi-directionally with many Burdick and

Quinton devices. The 6.2 version offers four new features versus the

prior release, namely:

• HeartCentrix 6.2 interfaces with the Burdick Universal ECG, a PC-based

  ECG solution;

• HeartCentrix 6.2 is certified with the Allscripts^®

  UAI interface;

• HeartCentrix 6.2 supports VISTA and remains Windows^®

  compatible; and

• HeartCentrix 6.2 allows local printing, supplementing EMR systems’

  printing capabilities.

“Connectivity is becoming more important in

cardiac diagnostic testing,” began René

Mitchell, director of diagnostic marketing for Cardiac Science. “In

fact, connectivity is so important that all our Burdick Atria^®

3100 or 6100 ECG devices now come with Ethernet communications as a

standard option. Cardiac Science is always seeking to provide greater

value to our customers–and this new

HeartCentrix release is one more way we meet that goal.”

HeartCentrix is easy to understand and use. Its familiar Windows-based

interface flows left to right in a logical progression. Using a single

sign-on from within the EMR, users can download orders and patient

demographics directly to Burdick and Quinton diagnostic devices, upload

results back to the EMR after tests are performed, and review and edit

test results at the office or any remote location.

About Cardiac Science

Cardiac Science develops, manufactures, and markets a family of advanced

diagnostic and therapeutic cardiology devices and systems, including

automated external defibrillators (AEDs), electrocardiograph devices

(ECGs), cardiac stress systems and treadmills, Holter monitoring

systems, hospital defibrillators, cardiac rehabilitation telemetry

systems, and cardiology data management systems (informatics) that

connect with hospital information (HIS), electronic medical record

(EMR), and other information systems. The Company sells a variety of

related products and consumables, and provides a portfolio of training,

maintenance, and support services. Cardiac Science, the successor to the

cardiac businesses that established the trusted Burdick^®,

HeartCentrix^®,

Powerheart^®, and

Quinton^® brands, is

headquartered in Bothell, Washington. With customers in more than 100

countries worldwide, the company has operations in North America,

Europe, and Asia. For information, call 425-402-2000 or visit www.cardiacscience.com.

Forward-Looking Statements

This press release contains forward-looking statements including, but

not limited to, those that infer that Cardiac Science Corporation’s

future revenue and profits may grow as a result of sales of the

HeartCentrix suite of connectivity products. These statements and their

underlying assumptions involve a number of risks and uncertainties and

are not guarantees of future performance. These are forward-looking

statements for purposes of the safe harbor provisions under the Private

Securities Litigation Reform Act of 1995. The words “believe,”

“expect,” “intend,”

anticipate,” variations of such words, and

similar expressions identify forward-looking statements, but their

absence does not mean that the statement is not forward looking. Actual

results may vary significantly from the results expressed or implied in

such statements. Factors that could cause or contribute to such varying

results and other risks that are more fully described in the Annual

Report on Form 10-K filed by Cardiac Science Corporation for the year

ended December 31, 2007. Cardiac Science Corporation undertakes no duty

or obligation to update the information provided herein.

CSCX-G

Major Newsire & Press Release Distribution with Basic Starting at only $19 and Complete OTCBB / Financial Distribution only $89

Get Unlimited Organic Website Traffic to your Website 
TheNFG.com now offers Organic Lead Generation & Traffic Solutions